118 related articles for article (PubMed ID: 24141373)
1. Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma.
Ando H; Natsume A; Senga T; Watanabe R; Ito I; Ohno M; Iwami K; Ohka F; Motomura K; Kinjo S; Ito M; Saito K; Morgan R; Wakabayashi T
Cancer Chemother Pharmacol; 2014 Jan; 73(1):53-60. PubMed ID: 24141373
[TBL] [Abstract][Full Text] [Related]
2. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
4. Targeting the HOX/PBX dimer in breast cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
[TBL] [Abstract][Full Text] [Related]
6. Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
Friedrich S; Schwabe K; Grote M; Krauss JK; Nakamura M
Acta Neurochir (Wien); 2013 Jan; 155(1):173-82. PubMed ID: 23143216
[TBL] [Abstract][Full Text] [Related]
7. The integrin inhibitor cilengitide affects meningioma cell motility and invasion.
Wilisch-Neumann A; Kliese N; Pachow D; Schneider T; Warnke JP; Braunsdorf WE; Böhmer FD; Hass P; Pasemann D; Helbing C; Kirches E; Mawrin C
Clin Cancer Res; 2013 Oct; 19(19):5402-12. PubMed ID: 23948974
[TBL] [Abstract][Full Text] [Related]
8. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
10. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
11. Targeting HOX transcription factors in prostate cancer.
Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
13. Targeting HOX-PBX interactions causes death in oral potentially malignant and squamous carcinoma cells but not normal oral keratinocytes.
Platais C; Radhakrishnan R; Niklander Ebensperger S; Morgan R; Lambert DW; Hunter KD
BMC Cancer; 2018 Jul; 18(1):723. PubMed ID: 29980182
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in the malignant transformation of meningiomas.
Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K
PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel.
Tichomirowa MA; Theodoropoulou M; Daly AF; Yassouridis A; Hansen S; Lu J; Lange M; Goldbrunner RH; Stalla GK; Renner U
Int J Cancer; 2008 Oct; 123(8):1956-63. PubMed ID: 18688857
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas.
Liu ZY; Wang JY; Liu HH; Ma XM; Wang CL; Zhang XP; Tao YQ; Lu YC; Liao JC; Hu GH
Oncogene; 2013 Mar; 32(10):1216-22. PubMed ID: 22614009
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the cell lines used in meningioma research.
Ragel BT; Couldwell WT; Gillespie DL; Wendland MM; Whang K; Jensen RL
Surg Neurol; 2008 Sep; 70(3):295-307; discussion 307. PubMed ID: 18261772
[TBL] [Abstract][Full Text] [Related]
18. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of genes differentially expressed in meningiomas.
Murphy M; Pykett MJ; Harnish P; Zang KD; George DL
Cell Growth Differ; 1993 Sep; 4(9):715-22. PubMed ID: 7694637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]